What is Lung cancer?

Gwrandewch ar y dudalen hon

Beth yw canser yr ysgyfaint?

Mae canser yr ysgyfaint yn fath o ganser sy'n dechrau yn yr ysgyfaint.

Mae'n digwydd pan fydd celloedd annormal yn yr ysgyfaint yn tyfu ac yn lluosogi'n ddi-reolaethol, gan ffurfio tumor.

Mae dau brif fath o ganser yr ysgyfaint: ganser yr ysgyfaint celloedd nad ydynt yn fach (NSCLC) a ganser yr ysgyfaint celloedd bach (SCLC). Y rheswm mwyaf cyffredin am ganser yr ysgyfaint yw ysmygu, ond gall hefyd gael ei achosi gan amlygiad i ysmygu arall, llygredd aer, a ffactorau amgylcheddol eraill.

Gall symptomau canser yr ysgyfaint gynnwys chwistrell parhaus, poen yn y frest, diffyg anadl, a chwistrellu gwaed.

Mae opsiynau triniaeth ar gyfer canser yr ysgyfaint yn cynnwys llawdriniaeth, therapi ymbelydredd, chemotherapi, therapi wedi'i dargedu, ac imiwnotherapi.

Gall canfod a thriniaeth gynnar wella'r siawns o oroesi.

Cyfeiriadau

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Liu Z, Zhao W, Yang R: MiR-1246 is responsible for lung cancer cells-derived exosomes-mediated promoting effects on lung cancer stemness via targeting TRIM17. Environ Toxicol. 2022, 37 (11): 2651-2659.

Lung Cancer Screening. Semin Respir Crit Care Med. 2022, 43 (6): 839-850.

Guan Y, Ren M, Guo D, He Y: [Research Progress on Lung Cancer Screening]. Zhongguo Fei Ai Za Zhi. 2020, 23 (11): 954-960.

Yu F, Xiao R, Li X, Hu Z, Cai L, He F: Combined effects of lung disease history, environmental exposures, and family history of lung cancer to susceptibility of lung cancer in Chinese non-smokers. Respir Res. 2021, 22 (1): 210.

Liu LZ, Qian GS, Zhou XD: [Expression of a new lung cancer drug resistance-related gene in lung cancer tissues and lung cancer cell strains]. Ai Zheng. 2003, 22 (2): 171-4.

Fan L, Wang Y, Zhou Y, Li Q, Yang W, Wang S, Shan F, Zhang X, Shi J, Chen W, Liu SY: Lung Cancer Screening with Low-Dose CT: Baseline Screening Results in Shanghai. Acad Radiol. 2019, 26 (10): 1283-1291.

Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K: Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel). 2014, 6 (2): 1157-79.

Jin Y, Zhou X, He X: [The general measurement of genetic factors on lung cancer in Xuanwei, China]. Zhongguo Fei Ai Za Zhi. 2001, 4 (5): 354-6.

Gwaharddiad cyfrifoldeb: meddygol

Mae'r wefan hon yn cael ei ddarparu at ddibenion addysgol a gwybodaeth yn unig ac nid yw'n darparu cyngor meddygol neu wasanaethau proffesiynol.

Ni ddylid defnyddio'r wybodaeth a ddarperir i ddiagnosio neu drin broblem neu glefyd iechyd, a dylai'r rhai sy'n ceisio cyngor meddygol personol ymgynghori â meddyg trwyddedig.

Sylwch fod y rhwydwaith niwrol sy'n cynhyrchu atebion i'r cwestiynau, yn arbennig o anghywir pan ddaw i gynnwys rhifol. Er enghraifft, nifer y bobl sy'n cael diagnosis o glefyd penodol.

Ceisiwch gyngor eich meddyg neu ddarparwr iechyd cymwys arall bob amser ynghylch cyflwr meddygol. Peidiwch byth ag anwybyddu cyngor meddygol proffesiynol neu ohirio ei geisio oherwydd rhywbeth rydych chi wedi ei ddarllen ar y wefan hon. Os ydych chi'n meddwl y gallai fod gennych argyfwng meddygol, ffonwch 911 neu ewch i'r ystafell brys agosaf ar unwaith. Nid oes unrhyw berthynas meddyg-cleifion yn cael ei greu gan y wefan hon na'i ddefnydd. Nid yw BioMedLib na'i weithwyr, na unrhyw gyfrannwr i'r wefan hon, yn gwneud unrhyw gynrychiolaeth, yn glir neu'n awgrymol, mewn perthynas â'r wybodaeth a ddarperir yma na'i ddefnydd.

Gwrthod cyfrifoldeb: hawlfraint

Mae Deddf Hawlfraint y Mileniwm Digidol o 1998, 17 U.S.C. § 512 (y DMCA) yn darparu adnodd i berchnogion hawlfraint sy'n credu bod deunydd sy'n ymddangos ar y Rhyngrwyd yn torri eu hawliau o dan gyfraith hawlfraint yr Unol Daleithiau.

Os ydych chi'n credu mewn ffydd da bod unrhyw gynnwys neu ddeunydd a wnaed ar gael mewn cysylltiad â'n gwefan neu'n gwasanaethau yn torri eich hawlfraint, gallwch chi (neu'ch asiant) anfon hysbysiad atom yn gofyn i'r cynnwys neu'r ddeunydd gael ei ddileu, neu fod mynediad ato wedi'i rwystro.

Rhaid i rybuddion gael eu hanfon yn ysgrifenedig trwy e-bost (gweler adran "Cyflwyniad" am gyfeiriad e-bost).

Mae'r DMCA yn gofyn i'ch hysbysiad o dorri hawlfraint honedig gynnwys y wybodaeth ganlynol: (1) disgrifiad o'r gwaith hawlfraint sy'n destun y dorri hawlfraint honedig; (2) disgrifiad o'r cynnwys sy'n dorri hawlfraint honedig a gwybodaeth ddigonol i'n galluogi i ddod o hyd i'r cynnwys; (3) gwybodaeth gyswllt i chi, gan gynnwys eich cyfeiriad, rhif ffôn a chyfeiriad e-bost; (4) datganiad gan chi bod gennych gred ffyddlon nad yw'r cynnwys yn y ffordd sy'n cwyno amdano wedi'i awdurdodi gan berchennog yr hawlfraint, neu ei asiant, neu gan weithredu unrhyw gyfraith;

(5) datganiad gennych chi, wedi'i lofnodi o dan gosb llygredd, bod y wybodaeth yn y hysbysiad yn gywir ac bod gennych chi'r awdurdod i orfodi'r hawlfraint sy'n cael eu troseddu;

a (6) llofnod corfforol neu electronig o berchennog y hawlfraint neu berson wedi'i awdurdodi i weithredu ar ran perchennog y hawlfraint.

Gall methu â chynnwys yr holl wybodaeth uchod arwain at oedi wrth brosesu'ch cwyn.

Cysylltwch

Anfonwch e-bost i ni gyda unrhyw gwestiwn / awgrym.

What is lung cancer?

Lung cancer is a type of cancer that begins in the lungs.

It occurs when abnormal cells in the lungs grow and multiply uncontrollably, forming a tumor.

There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The most common cause of lung cancer is smoking, but it can also be caused by exposure to secondhand smoke, air pollution, and other environmental factors.

Symptoms of lung cancer may include a persistent cough, chest pain, shortness of breath, and coughing up blood.

Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

Early detection and treatment can improve the chances of survival.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.